Home > Insider Trading > Filing (0001209191-15-008870)

Filing Details

Accession Number:: 0001209191-15-008870
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-03 16:48:58
Reporting Period:: 2015-02-01

Filing Date:: 2015-02-03
Accepted Time:: 2015-02-03 16:48:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1142596	Nuvasive Inc	NUVA	Surgical & Medical Instruments & Apparatus (3841)	330768598

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1289409	Patrick Miles	7475 Lusk Blvd. San Diego CA 92121	President And Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-02-01	48,115	$0.00	97,088	No	4	A	Direct
Common Stock	Disposition	2015-02-01	25,106	$46.32	71,982	No	4	F	Direct
Common Stock	Acquisiton	2015-02-01	12,021	$0.00	84,003	No	4	A	Direct
Common Stock	Disposition	2015-02-01	6,272	$46.32	77,731	No	4	F	Direct
Common Stock	Acquisiton	2015-02-01	9,165	$0.00	86,896	No	4	A	Direct
Common Stock	Disposition	2015-02-01	4,782	$46.32	82,114	No	4	F	Direct
Common Stock	Acquisiton	2015-02-01	5,304	$0.00	87,418	No	4	A	Direct
Common Stock	Disposition	2015-02-01	2,767	$46.32	84,651	No	4	F	Direct
Common Stock	Acquisiton	2015-02-02	9,491	$26.62	94,142	No	4	M	Direct
Common Stock	Disposition	2015-02-02	7,582	$45.93	86,560	No	4	F	Direct
Common Stock	Acquisiton	2015-02-02	22,396	$27.46	108,956	No	4	M	Direct
Common Stock	Disposition	2015-02-02	18,088	$45.93	90,868	No	4	F	Direct
Common Stock	Acquisiton	2015-02-02	64,246	$32.80	155,114	No	4	M	Direct
Common Stock	Disposition	2015-02-02	55,463	$45.93	99,651	No	4	F	Direct
Common Stock	Disposition	2015-02-03	15,000	$45.53	84,651	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	F	Direct
No	4	A	Direct
No	4	F	Direct
No	4	A	Direct
No	4	F	Direct
No	4	A	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2015-02-02	9,491	$0.00	9,491	$26.62
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2015-02-02	22,396	$0.00	22,396	$27.46
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2015-02-02	64,246	$0.00	64,246	$32.80

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2021-01-03	No	4	M	Direct
2021-01-28	No	4	M	Direct
2020-01-04	No	4	M	Direct

Footnotes

Settlement of the remaining one-half of the Performance Restricted Stock Units (PRSUs) granted on March 1, 2013. The performance criteria for such PRSUs was confirmed by the Issuer's Compensation Committee on January 24, 2014.
Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
Shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting/settlement of PRSUs dated March 1, 2013.
Settlement of vested shares under Restricted Stock Unit grant dated February 13, 2012.
Shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting/settlement of Restricted Stock Unit awards dated February 13, 2012.
Settlement of vested shares under Restricted Stock Unit grant dated February 26, 2013.
Shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting/settlement of Restricted Stock Unit awards dated February 26, 2013.
Settlement of vested shares under Restricted Stock Unit grant dated February 19, 2014.
Shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting/settlement of Restricted Stock Unit awards dated February 19, 2014.
Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on November 7, 2014, which is intended to comply with Rule 10b5-1.
Weighted average from 54 transactions with prices ranging from $45.2100 to $45.9750. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
The option, representing a right to purchase a total of 91,248 shares, became exercisable as follows: 25% of the shares vested on January 3, 2012; 1/48th of the remaining shares vested monthly thereafter so that all shares were fully vested as of January 3, 2015, subject to continued employment through each vesting period.
The option, representing a right to purchase a total of 24,479 shares, became exercisable as follows: 25% of the shares vested on January 28, 2012; the remaining shares vested monthly thereafter so that all shares were fully vested as of January 28, 2015, subject to continued employment through each vesting period.
The option, representing a right to purchase a total of 122,395 shares, became exercisable as follows: 25% of the shares vested on January 4, 2011; the remaining shares vested monthly thereafter so that all shares were fully vested as of January 4, 2014, subject to continued employment through each vesting period.